• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机械治疗联合辅助全身抗生素治疗牙周炎患者的龈下菌群长期变化:一项随机对照试验的二次分析。

Long-term changes in the subgingival microbiota in patients with stage III-IV periodontitis treated by mechanical therapy and adjunctive systemic antibiotics: A secondary analysis of a randomized controlled trial.

机构信息

Department of Periodontology and Operative Dentistry, Muenster University Hospital, Münster, Germany.

Department of Clinical Epidemiology, Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

出版信息

J Clin Periodontol. 2023 Aug;50(8):1101-1112. doi: 10.1111/jcpe.13824. Epub 2023 May 9.

DOI:10.1111/jcpe.13824
PMID:37160709
Abstract

AIM

To explore whether adjunctive antibiotics can relevantly influence long-term microbiota changes in stage III-IV periodontitis patients.

MATERIALS AND METHODS

This is a secondary analysis of a randomized clinical trial on periodontal therapy with adjunctive 500 mg amoxicillin and 400 mg metronidazole or placebo thrice daily for 7 days. Subgingival plaque samples were taken before and 2, 8, 14 and 26 months after mechanical therapy. The V4-hypervariable region of the 16S rRNA gene was sequenced with Illumina MiSeq 250 base pair paired-end reads. Changes at the ribosomal sequence variant (RSV) level, diversity and subgingival-microbial dysbiosis index (SMDI) were explored with a negative binomial regression model and non-parametric tests.

RESULTS

Overall, 50.2% of all raw reads summed up to 72 RSVs (3.0%) that were generated from 163 stage III-IV periodontitis patients. Of those, 16 RSVs, including Porphyromonas gingivalis, Tannerella forsythia and Aggregatibacter actinomycetemcomitans, changed significantly over 26 months because of adjunctive systemic antibiotics. SMDI decreased significantly more in the antibiotic group at all timepoints, whereas the 2-month differences in alpha and beta diversity between groups were not significant at 8 and 14 months, respectively.

CONCLUSIONS

Mechanical periodontal therapy with adjunctive antibiotics induced a relevant and long-term sustainable change towards an oral microbiome more associated with oral health.

摘要

目的

探讨辅助使用抗生素是否能显著影响牙周炎 III-IV 期患者的长期菌群变化。

材料和方法

这是一项牙周治疗辅助使用 500mg 阿莫西林和 400mg 甲硝唑或安慰剂,每日 3 次,连续 7 天的随机临床试验的二次分析。在机械治疗前、2、8、14 和 26 个月后采集龈下菌斑样本。使用 Illumina MiSeq 250 碱基对配对末端读取对 16S rRNA 基因的 V4 高变区进行测序。使用负二项回归模型和非参数检验探索核糖体序列变异(RSV)水平、多样性和龈下微生物失调指数(SMDI)的变化。

结果

总体而言,所有原始读数的 50.2%总和为 72 个 RSV(3.0%),这些 RSV 来自 163 名牙周炎 III-IV 期患者。其中,16 个 RSV,包括牙龈卟啉单胞菌、福赛斯坦纳菌和伴放线放线杆菌,由于辅助全身使用抗生素,在 26 个月内发生了显著变化。在所有时间点,抗生素组的 SMDI 显著降低,而在 8 个月和 14 个月时,两组之间的 alpha 和 beta 多样性的 2 个月差异分别无统计学意义。

结论

机械牙周治疗辅助使用抗生素可显著诱导与口腔健康更相关的长期可持续口腔微生物组变化。

相似文献

1
Long-term changes in the subgingival microbiota in patients with stage III-IV periodontitis treated by mechanical therapy and adjunctive systemic antibiotics: A secondary analysis of a randomized controlled trial.机械治疗联合辅助全身抗生素治疗牙周炎患者的龈下菌群长期变化:一项随机对照试验的二次分析。
J Clin Periodontol. 2023 Aug;50(8):1101-1112. doi: 10.1111/jcpe.13824. Epub 2023 May 9.
2
Significant Short-Term Shifts in the Microbiomes of Smokers With Periodontitis After Periodontal Therapy With Amoxicillin & Metronidazole as Revealed by 16S rDNA Amplicon Next Generation Sequencing.16S rDNA 扩增子高通量测序揭示牙周炎吸烟者牙周治疗后微生物组的短期显著变化:阿莫西林和甲硝唑治疗。
Front Cell Infect Microbiol. 2020 May 5;10:167. doi: 10.3389/fcimb.2020.00167. eCollection 2020.
3
Effects on clinical outcomes of adjunctive moxifloxacin versus amoxicillin plus metronidazole in periodontitis patients harboring Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia: exploratory analyses from a clinical trial.携带伴放线放线杆菌、牙龈卟啉单胞菌和福赛坦纳菌的牙周炎患者中莫西沙星辅助治疗与阿莫西林+甲硝唑治疗对临床结局的影响:一项临床试验的探索性分析。
Quintessence Int. 2021;52(1):20-29. doi: 10.3290/j.qi.a44927.
4
Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis.我们在牙周治疗中是治疗患者还是牙周微生物,或者用辅助抗生素治疗牙周微生物?一项 16S rDNA 微生物群落分析。
PLoS One. 2018 Apr 18;13(4):e0195534. doi: 10.1371/journal.pone.0195534. eCollection 2018.
5
Impact of baseline microbiological status on clinical outcomes in generalized aggressive periodontitis patients treated with or without adjunctive amoxicillin and metronidazole: an exploratory analysis from a randomized controlled clinical trial.基线微生物学状态对接受或未接受阿莫西林和甲硝唑辅助治疗的广泛侵袭性牙周炎患者临床结局的影响:一项随机对照临床试验的探索性分析
J Clin Periodontol. 2014 Nov;41(11):1080-9. doi: 10.1111/jcpe.12299. Epub 2014 Sep 11.
6
The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial.甲硝唑和阿莫西林在晚期牙周病治疗中的应用。一项前瞻性对照临床试验。
J Clin Periodontol. 1998 May;25(5):354-62. doi: 10.1111/j.1600-051x.1998.tb02455.x.
7
Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis.患有伴放线放线杆菌和/或牙龈卟啉单胞菌的患者在接受全身性甲硝唑和阿莫西林治疗后的临床治疗结果差异
J Clin Periodontol. 1998 May;25(5):380-7. doi: 10.1111/j.1600-051x.1998.tb02459.x.
8
Antimicrobial resistance of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in periodontitis patients.牙周炎患者中伴放线聚集杆菌、牙龈卟啉单胞菌和福赛坦纳菌的耐药性。
J Glob Antimicrob Resist. 2020 Sep;22:215-218. doi: 10.1016/j.jgar.2020.02.024. Epub 2020 Mar 10.
9
Effect of adjunctive systemic antibiotics on microbial populations compared with scaling and root planing alone for the treatment of periodontitis: A pilot randomized clinical trial.辅助全身抗生素治疗与单独牙周洁治和根面平整治疗牙周炎的微生物种群比较:一项初步的随机临床试验。
J Periodontol. 2022 Apr;93(4):570-583. doi: 10.1002/JPER.20-0764. Epub 2021 Sep 14.
10
Effects of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans on Modeling Subgingival Microbiome and Impairment of Oral Epithelial Barrier.牙龈卟啉单胞菌和伴放线放线杆菌对龈下微生物组建模和口腔上皮屏障损伤的影响。
J Infect Dis. 2024 Jan 12;229(1):262-272. doi: 10.1093/infdis/jiad461.

引用本文的文献

1
Impact of Antibiotics on the Subgingival Microbiome in Advanced Periodontitis: Secondary Analysis of a Randomized Controlled Trial.抗生素对重度牙周炎患者龈下微生物群的影响:一项随机对照试验的二次分析
Diagnostics (Basel). 2025 Aug 11;15(16):2012. doi: 10.3390/diagnostics15162012.
2
Potential short-term shift in oral microbiota of patients with stage III-IV periodontitis and type 2 diabetes treated by non-surgical periodontal therapy.非手术牙周治疗对III-IV期牙周炎合并2型糖尿病患者口腔微生物群的潜在短期影响。
J Dent Sci. 2025 Jul;20(3):1470-1479. doi: 10.1016/j.jds.2025.01.014. Epub 2025 Jan 28.
3
Periodontal disease and chronic kidney disease: mechanistic insights and novel therapeutic perspectives.
牙周病与慢性肾病:机制洞察与新型治疗前景
Front Cell Infect Microbiol. 2025 Jun 25;15:1611097. doi: 10.3389/fcimb.2025.1611097. eCollection 2025.
4
Endpoints of Periodontal Therapy in Elderly Patients With Stage III/IV Periodontitis and Their Oral Health-Related Quality of Life Following 10 Years of Supportive Periodontal Therapy.老年III/IV期牙周炎患者牙周治疗的终点及其在10年支持性牙周治疗后的口腔健康相关生活质量
J Clin Periodontol. 2025 Oct;52(10):1398-1409. doi: 10.1111/jcpe.14198. Epub 2025 Jul 6.
5
Association of supragingival plaque management with subgingival microbiota is moderated by adjunctive antibiotics in stage III-IV periodontitis patients during periodontal therapy.在牙周治疗期间,辅助性抗生素可调节III-IV期牙周炎患者龈上菌斑管理与龈下微生物群之间的关联。
J Oral Microbiol. 2025 Jun 14;17(1):2517043. doi: 10.1080/20002297.2025.2517043. eCollection 2025.
6
A retrospective study on the impact of different antibiotic regimens in non-surgical periodontal therapy on microbial loads and therapy outcomes.一项关于非手术牙周治疗中不同抗生素治疗方案对微生物负荷及治疗效果影响的回顾性研究。
Front Oral Health. 2025 May 14;6:1578484. doi: 10.3389/froh.2025.1578484. eCollection 2025.
7
The impact of Limosilactobacillus reuteri in combination with non-surgical periodontal therapy on periodontal clinical parameters and salivary and subgingival microbiota composition in individuals with stage III-IV periodontitis: a randomized controlled trial.罗伊氏乳杆菌联合非手术牙周治疗对III-IV期牙周炎患者牙周临床参数、唾液及龈下微生物群组成的影响:一项随机对照试验
BMC Oral Health. 2025 May 22;25(1):759. doi: 10.1186/s12903-025-06084-1.
8
Impact of Prolonged Fasting on the Oral Microbiome in Patients With Metabolic Syndrome: An Exploratory Secondary Analysis.长期禁食对代谢综合征患者口腔微生物群的影响:一项探索性二次分析
J Clin Periodontol. 2025 Aug;52(8):1125-1135. doi: 10.1111/jcpe.14171. Epub 2025 May 12.
9
The role of the oral microbiota in the causal effect of adjunctive antibiotics on clinical outcomes in stage III-IV periodontitis patients.口腔微生物群在辅助抗生素对 III-IV 期牙周炎患者临床结局的因果效应中的作用。
Microbiome. 2024 Oct 26;12(1):220. doi: 10.1186/s40168-024-01945-3.
10
Synergistic Effect of Metronidazole and Chlorhexidine against Growth: An In Vitro Study.甲硝唑与氯己定联合对生长的协同作用:一项体外研究
Dent J (Basel). 2024 Sep 27;12(10):307. doi: 10.3390/dj12100307.